Double, Kay L.

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell

Parkinson's Disease Mechanisms and TreatmentsRedox biology and oxidative stress

Cited by 778

Brain iron pathways and their relevance to Parkinson's disease

Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 362

Copper pathology in vulnerable brain regions in Parkinson's disease

Davies, K. M., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D. J., Finberg, J. P. M., Reyes, S., Halliday, G. M., Mercer, J. F. B., et al. (2014) · Neurobiology of Aging

Parkinson's Disease Mechanisms and TreatmentsTrace Elements in Health

Cited by 244

Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway

Purves-Tyson, T. D., Owens, S. J., Double, K. L., Desai, R., Handelsman, D. J., & Weickert, C. S. (2014) · PLoS ONE

Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

Cited by 109

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology

Parkinson's Disease Mechanisms and Treatmentsmelanin and skin pigmentation

Cited by 102

Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease

Gerlach, M., Riederer, P., & Double, K. L. (2008) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 33